Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Industry News

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

August 07, 2019

News Industry News

EFFPAC RCT 24-month has revealed in EuroPCR 2019 that Luminor DCB demonstrate a non-increase of risk of death at 24-month follow-up

May 23, 2019

News Industry News

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

July 28, 2016

News Industry News

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

April 07, 2016

News Industry News

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

February 21, 2016

News Industry News

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

February 08, 2016

News Industry News

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

January 25, 2016

News Industry News

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

November 02, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

News Industry News

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

September 29, 2015

News Industry News

Boston Scientific Announces FDA Approval of Innova™ Vascular Self-Expanding Stent System

August 19, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Industry News

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

August 03, 2015

News Industry News

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

July 29, 2015

News Industry News

Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease

July 21, 2015

News Industry News

First Subject Enrolled in Veryan Medical's MIMICS-2 Study

July 01, 2015

Advertisement

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

EFFPAC RCT 24-month has revealed in EuroPCR 2019 that Luminor DCB demonstrate a non-increase of risk of death at 24-month follow-up

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

Boston Scientific Announces FDA Approval of Innova™ Vascular Self-Expanding Stent System

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease

First Subject Enrolled in Veryan Medical's MIMICS-2 Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content